LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 80 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $177,713 | -50.0% | 121,165 | +8.4% | 0.00% | – |
| Q2 2023 | $355,439 | +844.4% | 111,773 | +596.4% | 0.00% | – |
| Q1 2023 | $37,635 | -32.5% | 16,049 | 0.0% | 0.00% | – |
| Q4 2022 | $55,770 | -52.3% | 16,049 | 0.0% | 0.00% | – |
| Q3 2022 | $117,000 | +23.2% | 16,049 | +9.7% | 0.00% | – |
| Q2 2022 | $95,000 | +31.9% | 14,626 | +3.1% | 0.00% | – |
| Q1 2022 | $72,000 | +323.5% | 14,187 | +546.0% | 0.00% | – |
| Q4 2021 | $17,000 | -48.5% | 2,196 | 0.0% | 0.00% | – |
| Q3 2021 | $33,000 | +312.5% | 2,196 | +361.3% | 0.00% | – |
| Q2 2021 | $8,000 | – | 476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $69,963,292 | 35.72% |
| Orland Properties Ltd | 15,093,969 | $52,376,072 | 27.91% |
| Foresite Capital Management IV, LLC | 10,000,000 | $34,700,000 | 14.82% |
| MIC Capital Management UK LLP | 3,060,569 | $10,620,174 | 2.10% |
| Alphabet Inc. | 5,865,125 | $20,351,984 | 1.18% |
| HSG Holding Ltd | 3,045,997 | $10,569,610 | 1.07% |
| Artal Group S.A. | 700,000 | $2,429 | 0.14% |
| Eagle Health Investments LP | 100,000 | $347,000 | 0.08% |
| Virtus ETF Advisers LLC | 39,345 | $136,527 | 0.07% |
| BBR PARTNERS, LLC | 164,041 | $569,222 | 0.06% |